Interactive Models on Pharmaceuticals and Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | » »|

Type Product title / description Pub Price
Interactive Model
Interactive Model

Medtrack: Autoimmune and Inflammation Pipeline Databook - May 2013

This in-depth Excel databook covers the autoimmune and inflammation pipeline by company and phase.

Published By Datamonitor
31 May 2013 $2900
Buy
Interactive Model
Interactive Model

Medtrack: Infectious Diseases Pipeline Databook - May 2013

This in-depth Excel databook covers the infectious diseases pipeline by company and phase.

Published By Datamonitor
31 May 2013 $2900
Buy
Interactive Model
Interactive Model

Medtrack: Kidneys and Genitourinary System Pipeline Databook - May 2013

This in-depth Excel databook covers the kidneys and genitourinary system pipeline by company and phase.

Published By Datamonitor
31 May 2013 $2900
Buy
Interactive Model
Interactive Model

The Depression Market Forecast to 2021

The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.

Published By Datamonitor
25 Apr 2013 $6400
Buy
Interactive Model
Interactive Model

The Hepatitis C Market Forecast to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
17 Apr 2013 $6400
Buy
Interactive Model
Interactive Model

The Inflammatory Bowel Disease Market Forecast to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
22 Mar 2013 $6400
Buy
Interactive Model
Interactive Model

The Vaccines Market Forecast to 2021

Strong growth expected in the vaccines market, as Sanofi Pasteur and Merck continue to dominate over the next 10 years.

Published By Datamonitor
13 Feb 2013 $6400
Buy
Interactive Model
Interactive Model

The Market Forecast for Hepatitis C in China to 2021

The Chinese hepatitis C market will experience an increase in sales over the forecast period.

Published By Datamonitor
04 Feb 2013 $6400
Buy
Interactive Model
Interactive Model

The Dyslipidemia Market Forecast to 2021

In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.

Published By Datamonitor
04 Feb 2013 $6400
Buy
Interactive Model
Interactive Model

Treatment of Hepatitis C in China

Datamonitor’s survey of 46 specialists in Tier 1 and Tier 2 cities in China sheds light on treatment patterns and prescribing influences

Published By Datamonitor
29 Jan 2013 $3800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | » »|

No help is available.